Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma

Clinical trial NCT02992834 · UNKNOWN

Trial details

NCT number: NCT02992834
Sponsor: jiangjingting
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Lymphoma, B Cell

Start date: 2016-12-01
Primary completion: 2020-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.